Abstract:Objective: To develop an MR optical dual-modality probe targeting angiogenesis of gastric; cancer and to study its physical characteristics, in vitro cytotoxicity and magnetic effects of different pulse sequences on 3 T clinical MR scanner. Methods: We conjugated GXl-Cy5.5, a novel gastric cancer neo-vasculature targeted peptide labeled with Cy5.5, to the surface functionalized magnetic: nanoparticles according to different molecular weights (1:100, 1:500), resulting in dual-modality probe DPs, and DPs (named DPs). The hydrodynamic size and zeta potential of DPs and DPs were analyzed by nano-ZS. The human umbilical vein endothelial cells (HUVECs) and BGC-823 cells were treated with DPs for 24 h, and methyl thiazol tetrazolium (MTT) method was used to detect the survival rate of cells. DPs with different concentrations were scanned on different MR sequences, and then the relative signal intensity was observed. The absorbance of HUVECs and BGC823 cells treated with DPs of different concentration (0.00, 1.25, 2.50, 15.00, 50.00, 100.00 and 150.00 (xg/ml) were compared with single factor analysis of variance. Relative signal intensity of different MR sequences was compared using a paired Wilcoxon signed-rank test. Results: The dual-modality probe targeting angiogenesis of gastric cancer was successfully constructed. The hydrodynamic size of iron oxide nanoparticles, DPs and DPswas (35.23±0.07), (39.49±0.16) and (40.43±1.70) nm and the Zeta potential was (0.31±0.20), (-4.15±0.79) and (-10.51±2.37) mV. The coupled rates of DPs and DPs with polypeptide were 92% and 94% respectively. The absorbance of HUVECs and BGC823 cells treated with DPs of different concentrations were 0.76±0.04, 0.80±0.03, 0.79±0.05, 0.75±0.06, 0.74±0.05, 0.77±0.01, 0.71±0.04 and 0.38±0.04, 0.43±0.04, 0.41±0.03, 0.43±0.07, 0.44±0.04, 0.41±0.07 and 0.40±0.04, there was no statistical significance (F=0.94, 0.51; P≤0.05). The signal intensity increased first and then decreased following the increasing concentrations of DPs on TWI, especially on FSPGR TWI (Z=-3.294, P 10 μg/ml, the signal intensity on SSFSE TWI was significantly decreased compared to FSE TWI (Z=-2.023, P<0.05). Conclusions: DPs may be potential dual-modal probes for characterization of tumor angiogenesis by MR and optical imaging noninvasively, without causing significant effects on the cell activity in vitro, and SSFSE TWI may be the most sensitive sequence for DPs evaluation on MR.

MR Imaging of Tumor Angiogenesis Using Sterically Stabilized Gd-DTPA Liposomes Targeted to CD105.

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Visualization of Tumor Angiogenesis Using MR Imaging Contrast Agent Gd-DTPA-anti-VEGF Receptor 2 Antibody Conjugate in a Mouse Tumor Model

Positron Emission Tomography Imaging of CD105 Expression During Tumor Angiogenesis

Preparation and characterization of dual-modality molecular probes for imaging angiogenesis of gastric cancer

Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins.

Thiol-PEG-carboxyl-stabilized Fe₂O ₃/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis.

Multimodality Molecular Imaging of CD105 (endoglin) Expression.

Preparation and in Vitro Evaluation of a MRI Contrast Agent Based on Aptamer-Modified Gadolinium-Loaded Liposomes for Tumor Targeting

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

In Vitro Study of Novel Gadolinium-Loaded Liposomes Guided by GBI-10 Aptamer for Promising Tumor Targeting and Tumor Diagnosis by Magnetic Resonance Imaging

In Vivo Near-Infrared Fluorescence Imaging of CD105 Expression During Tumor Angiogenesis

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.

Active targeted dual-modal CT/MR imaging of VX2 tumors using PEGylated BaGdF5 nanoparticles conjugated with RGD

High-Resolution Magnetic Resonance Angiography of Tumor Vasculatures with an Interlocking Contrast Agent

Coupling Gd-DTPA with a Bispecific, Recombinant Protein Anti-Egfr-irgd Complex Improves Tumor Targeting in MRI

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors